Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC)

by Wenguang Wang, Zhilu Gan, Qiang Liu, Shenshen Yan, Rexiti Mulati, Yujie Wang
Published 2021-01-01